Therefore, treatment with a ROCK inhibitor may significantly decrease the invasion area and the number of invaded cancer cells owing to podoplanin overexpression-dependent enhancement of RhoA activity in CAFs [28]. The gene discussed is RHOA; the disease is cancer.